Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A diffuse malignant mesothelioma arising from the pleura and less often the peritoneum. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen.
Biomarker and diagnostic research for sarcomatoid mesothelioma has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 2 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
21 publications have been identified in PubMed for sarcomatoid mesothelioma. Research spans Case Report / Case Series (43%), Review / Meta-Analysis (29%), and Diagnostic / Biomarker (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:39 AM UTC
43%
Research summaries | 6 | 29% |
Testing and diagnosis research | 4 | 19% |
Clinical study results | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Xia L (2026). [PMID: 41640977](https://pubmed.ncbi.nlm.nih.gov/41640977/). *Respiratory medicine case reports*. [Case Report / Case Series]
Ollila H (2026). [PMID: 41986072](https://pubmed.ncbi.nlm.nih.gov/41986072/). *J Immunother Cancer*. [Case Report / Case Series]
Alqaidy D (2026). [PMID: 41347458](https://pubmed.ncbi.nlm.nih.gov/41347458/). *Advances in anatomic pathology*. [Case Report / Case Series]
Sallé FG (2026). [PMID: 41962769](https://pubmed.ncbi.nlm.nih.gov/41962769/). *J Thorac Oncol*. [Review / Meta-Analysis]
Al Achkar Z (2026). [PMID: 42026555](https://pubmed.ncbi.nlm.nih.gov/42026555/). *BMC Pulm Med*. [Review / Meta-Analysis]
Nezafati P (2026). [PMID: 42052488](https://pubmed.ncbi.nlm.nih.gov/42052488/). *Front Oncol*. [Case Report / Case Series]
Thabit DM (2026). [PMID: 42135065](https://pubmed.ncbi.nlm.nih.gov/42135065/). *J Clin Pathol*. [Diagnostic / Biomarker]
Lapidot M (2026). [PMID: 41659271](https://pubmed.ncbi.nlm.nih.gov/41659271/). *Translational lung cancer research*. [Diagnostic / Biomarker]
Rossi T (2025). [PMID: 40673099](https://pubmed.ncbi.nlm.nih.gov/40673099/). *Translational lung cancer research*. [Epidemiology / Natural History]
Vtorushin SV (2025). [PMID: 40531560](https://pubmed.ncbi.nlm.nih.gov/40531560/). *Arkh Patol*. [Review / Meta-Analysis]